VERA THERAPEUTICS INC's ticker is VERA and the CUSIP is 92337R101. A total of 38 filers reported holding VERA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $135,551 | -14.6% | 9,887 | 0.0% | 0.01% | -14.3% |
| Q2 2023 | $158,686 | +106.8% | 9,887 | 0.0% | 0.01% | +75.0% |
| Q1 2023 | $76,723 | +40069.1% | 9,887 | 0.0% | 0.00% | -55.6% |
| Q4 2022 | $191 | -99.9% | 9,887 | 0.0% | 0.01% | -10.0% |
| Q3 2022 | $211,000 | +56.3% | 9,887 | 0.0% | 0.01% | +66.7% |
| Q2 2022 | $135,000 | -41.8% | 9,887 | 0.0% | 0.01% | -25.0% |
| Q1 2022 | $232,000 | -12.1% | 9,887 | 0.0% | 0.01% | -11.1% |
| Q4 2021 | $264,000 | – | 9,887 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kynam Capital Management, LP | 3,372,428 | $26,170,041 | 3.38% |
| COMMODORE CAPITAL LP | 2,824,029 | $21,914,465 | 3.34% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 1,002,257 | $7,747,447 | 2.16% |
| Sofinnova Investments, Inc. | 3,467,156 | $26,905,131 | 1.72% |
| Altium Capital Management LP | 286,000 | $2,219,360 | 1.23% |
| Eversept Partners, LP | 1,788,529 | $13,878,985 | 0.97% |
| SECTORAL ASSET MANAGEMENT INC | 600,300 | $4,658,328 | 0.90% |
| Octagon Capital Advisors LP | 795,000 | $6,169,200 | 0.89% |
| Carlyle Group Inc. | 2,960,231 | $22,882,586 | 0.68% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,300,000 | $10,088,000 | 0.22% |